Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600851.SS Gross Margin

The Gross Margin of Shanghai Haixin Group Co Ltd (600851.SS) is 53.14%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

600851.SS Gross Margin - Historical Value
Date Value
2024-12-31 53.14%
2023-12-31 46.37%
2022-12-31 43.73%
2021-12-31 46.23%
2020-12-31 45.27%
2019-12-31 40.80%
2018-12-31 40.11%
2017-12-31 29.94%
2016-12-31 13.80%
2015-12-31 23.36%
600851.SS Gross Margin - Peers Comparison
Ticker Name Value
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 72.18%
002550.SZ Changzhou Qianhong Biopharma Co Ltd 54.65%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 8.72%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 78.16%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 69.43%
603566.SS Pulike Biological Engineering Inc 60.99%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 60.48%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 58.25%
300723.SZ ApicHope Pharmaceutical Co Ltd 60.37%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 47.37%
300006.SZ Chongqing Lummy Pharmaceutical Co Ltd 63.27%
603222.SS Chimin Health Management Co Ltd 35.72%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 30.85%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 54.20%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 63.30%
000915.SZ Shandong WIT Dyne Health Co Ltd 83.80%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 74.19%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 57.03%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 41.83%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.02%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 51.05%
300110.SZ Huaren Pharmaceutical Co Ltd 34.55%
300199.SZ Hybio Pharmaceutical Co Ltd 52.73%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 73.01%
603669.SS Lionco Pharmaceutical Group Co Ltd 45.81%
605116.SS Aurisco Pharmaceutical Co Ltd 55.31%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 79.78%
600624.SS Shanghai Fudan Forward S&T Co Ltd 42.73%